Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature

Abstract Primary Sjögren’s syndrome (SS) is a systemic autoimmune disease characterized by lymphocytic infiltration and damage of exocrine salivary and lacrimal glands. The etiology of SS is complex with environmental triggers and genetic factors involved. By conducting an integrated multi-omics stu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: María Teruel, Guillermo Barturen, Manuel Martínez-Bueno, Olivia Castellini-Pérez, Miguel Barroso-Gil, Elena Povedano, Martin Kerick, Francesc Català-Moll, Zuzanna Makowska, Anne Buttgereit, PRECISESADS Clinical Consortium, PRECISESADS Flow Cytometry Study Group, Jacques-Olivier Pers, Concepción Marañón, Esteban Ballestar, Javier Martin, Elena Carnero-Montoro, Marta E. Alarcón-Riquelme
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3eee442ab7cc476caac7987d806bfc0e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3eee442ab7cc476caac7987d806bfc0e
record_format dspace
spelling oai:doaj.org-article:3eee442ab7cc476caac7987d806bfc0e2021-12-05T12:15:50ZIntegrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature10.1038/s41598-021-01324-02045-2322https://doaj.org/article/3eee442ab7cc476caac7987d806bfc0e2021-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-01324-0https://doaj.org/toc/2045-2322Abstract Primary Sjögren’s syndrome (SS) is a systemic autoimmune disease characterized by lymphocytic infiltration and damage of exocrine salivary and lacrimal glands. The etiology of SS is complex with environmental triggers and genetic factors involved. By conducting an integrated multi-omics study, we confirmed a vast coordinated hypomethylation and overexpression effects in IFN-related genes, what is known as the IFN signature. Stratified and conditional analyses suggest a strong interaction between SS-associated HLA genetic variation and the presence of Anti-Ro/SSA autoantibodies in driving the IFN epigenetic signature and determining SS. We report a novel epigenetic signature characterized by increased DNA methylation levels in a large number of genes enriched in pathways such as collagen metabolism and extracellular matrix organization. We identified potential new genetic variants associated with SS that might mediate their risk by altering DNA methylation or gene expression patterns, as well as disease-interacting genetic variants that exhibit regulatory function only in the SS population. Our study sheds new light on the interaction between genetics, autoantibody profiles, DNA methylation and gene expression in SS, and contributes to elucidate the genetic architecture of gene regulation in an autoimmune population.María TeruelGuillermo BarturenManuel Martínez-BuenoOlivia Castellini-PérezMiguel Barroso-GilElena PovedanoMartin KerickFrancesc Català-MollZuzanna MakowskaAnne ButtgereitPRECISESADS Clinical ConsortiumPRECISESADS Flow Cytometry Study GroupJacques-Olivier PersConcepción MarañónEsteban BallestarJavier MartinElena Carnero-MontoroMarta E. Alarcón-RiquelmeNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-18 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
María Teruel
Guillermo Barturen
Manuel Martínez-Bueno
Olivia Castellini-Pérez
Miguel Barroso-Gil
Elena Povedano
Martin Kerick
Francesc Català-Moll
Zuzanna Makowska
Anne Buttgereit
PRECISESADS Clinical Consortium
PRECISESADS Flow Cytometry Study Group
Jacques-Olivier Pers
Concepción Marañón
Esteban Ballestar
Javier Martin
Elena Carnero-Montoro
Marta E. Alarcón-Riquelme
Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
description Abstract Primary Sjögren’s syndrome (SS) is a systemic autoimmune disease characterized by lymphocytic infiltration and damage of exocrine salivary and lacrimal glands. The etiology of SS is complex with environmental triggers and genetic factors involved. By conducting an integrated multi-omics study, we confirmed a vast coordinated hypomethylation and overexpression effects in IFN-related genes, what is known as the IFN signature. Stratified and conditional analyses suggest a strong interaction between SS-associated HLA genetic variation and the presence of Anti-Ro/SSA autoantibodies in driving the IFN epigenetic signature and determining SS. We report a novel epigenetic signature characterized by increased DNA methylation levels in a large number of genes enriched in pathways such as collagen metabolism and extracellular matrix organization. We identified potential new genetic variants associated with SS that might mediate their risk by altering DNA methylation or gene expression patterns, as well as disease-interacting genetic variants that exhibit regulatory function only in the SS population. Our study sheds new light on the interaction between genetics, autoantibody profiles, DNA methylation and gene expression in SS, and contributes to elucidate the genetic architecture of gene regulation in an autoimmune population.
format article
author María Teruel
Guillermo Barturen
Manuel Martínez-Bueno
Olivia Castellini-Pérez
Miguel Barroso-Gil
Elena Povedano
Martin Kerick
Francesc Català-Moll
Zuzanna Makowska
Anne Buttgereit
PRECISESADS Clinical Consortium
PRECISESADS Flow Cytometry Study Group
Jacques-Olivier Pers
Concepción Marañón
Esteban Ballestar
Javier Martin
Elena Carnero-Montoro
Marta E. Alarcón-Riquelme
author_facet María Teruel
Guillermo Barturen
Manuel Martínez-Bueno
Olivia Castellini-Pérez
Miguel Barroso-Gil
Elena Povedano
Martin Kerick
Francesc Català-Moll
Zuzanna Makowska
Anne Buttgereit
PRECISESADS Clinical Consortium
PRECISESADS Flow Cytometry Study Group
Jacques-Olivier Pers
Concepción Marañón
Esteban Ballestar
Javier Martin
Elena Carnero-Montoro
Marta E. Alarcón-Riquelme
author_sort María Teruel
title Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
title_short Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
title_full Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
title_fullStr Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
title_full_unstemmed Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
title_sort integrative epigenomics in sjögren´s syndrome reveals novel pathways and a strong interaction between the hla, autoantibodies and the interferon signature
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/3eee442ab7cc476caac7987d806bfc0e
work_keys_str_mv AT mariateruel integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT guillermobarturen integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT manuelmartinezbueno integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT oliviacastelliniperez integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT miguelbarrosogil integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT elenapovedano integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT martinkerick integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT francesccatalamoll integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT zuzannamakowska integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT annebuttgereit integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT precisesadsclinicalconsortium integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT precisesadsflowcytometrystudygroup integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT jacquesolivierpers integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT concepcionmaranon integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT estebanballestar integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT javiermartin integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT elenacarneromontoro integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
AT martaealarconriquelme integrativeepigenomicsinsjogrenssyndromerevealsnovelpathwaysandastronginteractionbetweenthehlaautoantibodiesandtheinterferonsignature
_version_ 1718372070334660608